Functional Characteristics and Regulated Expression of Alternatively Spliced Tissue Factor: An Update

Area of Science:

• Molecular Biology
• Cancer Research
• Cell Signaling

Background:

• Alternative splicing of tissue factor (TF) produces two isoforms: full-length TF (flTF) and alternatively spliced TF (asTF).
• While flTF is a membrane glycoprotein crucial for hemostasis, the soluble asTF isoform has emerged as a significant factor in cancer pathobiology.
• asTF is dispensable for normal hemostasis but plays a role in malignant processes.

Purpose of the Study:

• To review the research on asTF, focusing on its role in cancer progression.
• To discuss the mechanisms by which asTF contributes to tumor development.
• To explore the potential of asTF as a biomarker and therapeutic target in oncology.

Main Methods:

• Literature review of pioneering and recent research on asTF.
• Analysis of current concepts regarding asTF's contribution to cancer.
• Discussion of asTF's emerging utility in clinical applications.

Main Results:

• asTF activates specific integrins on benign and malignant cells.
• asTF promotes outside-in signaling pathways involved in angiogenesis, cancer cell proliferation, migration, and invasion.
• asTF facilitates monocyte recruitment, contributing to the tumor microenvironment.

Conclusions:

• asTF significantly contributes to the pathobiology of solid malignancies.
• Understanding asTF's mechanisms offers insights into cancer progression.
• asTF presents emerging potential as a diagnostic biomarker and a therapeutic target for cancer treatment.